TK216 for relapsed/refractory Ewing sarcoma: Interim phase 1/2 results.

被引：17

作者：

Ludwig, Joseph Aloysius

Federman, Noah C.

Anderson, Peter Meade

Macy, Margaret E.

Riedel, Richard F.

Davis, Lara E.

Daw, Najat C.

Wulff, Jade

Kim, AeRang

Ratan, Ravin

Baskin-Bey, Edwina S.

Toretsky, Jeffrey A.

Breitmeyer, James Bradley

Meyers, Paul A.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Sarcoma Med Oncol, Houston, TX 77030 USA

[2] Univ Calif Los Angeles, Med Ctr, Pediat, Los Angeles, CA 90024 USA

[3] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[4] Univ Colorado, Pediat Hematol Oncol, Aurora, CO USA

[5] Childrens Hosp Colorado, Aurora, CO USA

[6] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA

[7] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[8] Univ Texas MD Anderson Canc Ctr, Pediat, Houston, TX 77030 USA

[9] Texas Childrens Hosp, Pediat, Houston, TX 77030 USA

[10] Childrens Natl Med Ctr, Washington, DC 20010 USA

[11] Oncternal Therapeut Inc, San Diego, CA USA

[12] Georgetown Univ, Dept Pediat, Washington, DC 20057 USA

[13] Georgetown Univ, Dept Oncol, Washington, DC USA

[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.11500

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

11500

引用

页数：3